课题基金 / 基金详情

Development of Key Technologies to Treat Aortic Aneurysms

Development of Key Technologies to Treat Aortic Aneurysms
主动脉瘤治疗关键技术进展
批准号:
104012
负责人:
金额:
$61.25万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project targets the treatment of abdominal aortic aneurysms; a fatal pathology most common in men in their mid sixties. It combines the clinical and medical implant skills of Lombard Medical with Microport's expertise in medical device manufacturing technology. This progam will develop a minimally invasive implant that can be used in day-case aneurysm surgery. This will save money for healthcare system world-wide and allow patients to return home and to a normal life as rapidly as possible. By investing in unprecedented levels of manufacturing automation, the companies expect to be able to deliver this therapeutic benefit at no additional cost to healthcare providers. Day case surgery for aneurysms is currently experimental and minimally invasive implants to treat aneurysms are almost completely hand-made. This project aims to take dramatic steps in both clinical and manufacturing technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
βB1 蛋白 L116P 突变通过 Greek key II 的稳定 性介导晶状体蛋白异常聚集的作用与机制研 究
  • 批准号:
    Q24H120009
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    刘健
  • 依托单位:
βB晶状体蛋白第四Greek Key基序调控晶状体蛋白稳态的分子机制
  • 批准号:
    LY23H120004
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    罗陈启
  • 依托单位:
“Lock and Key”策略构建二元共混体系中粒子刷相互作用新模型研究
  • 批准号:
    51973001
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2019
  • 负责人:
    张建安
  • 依托单位: